Authors: Camilleri, M Chey, WY Mayer, EA Northcutt, AR Heath, A Dukes, GE McSorley, D Mangel, AM

Citation: M. Camilleri et al., A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome, ARCH IN MED, 161(14), 2001, pp. 1733-1740

Authors: Wolfe, SG Chey, WY Washington, MK Harding, J Heath, AT McSorley, DJ Dukes, GE Hunt, CM

Citation: Sg. Wolfe et al., Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients, AM J GASTRO, 96(3), 2001, pp. 803-811

Authors: Camilleri, M Northcutt, AR Kong, S Dukes, GE McSorley, D Mangel, AW

Citation: M. Camilleri et al., Efficacy and safety of alosetron in women with irritable bowel syndrome: arandomised, placebo-controlled trial, LANCET, 355(9209), 2000, pp. 1035-1040

Authors: Camilleri, M Mayer, EA Drossman, DA Heath, A Dukes, GE McSorley, D Kong, S Mangel, AW Northcutt, AR

Citation: M. Camilleri et al., Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist, ALIM PHARM, 13(9), 1999, pp. 1149-1159